Order Article Reprints

Tamura Y, Ono A, Nakahara H, Hayes CN, Fujii Y, Zhang P, Yamauchi M, Uchikawa S, Teraoka Y, Uchida T, et al. Association of Hepatobiliary Phase of Gadoxetic-Acid-Enhanced MRI Imaging with Immune Microenvironment and Response to Atezolizumab Plus Bevacizumab Treatment. Cancers. 2023; 15(17):4234. https://doi.org/10.3390/cancers15174234

Tamura, Yosuke, Atsushi Ono, Hikaru Nakahara, Clair Nelson Hayes, Yasutoshi Fujii, Peiyi Zhang, Masami Yamauchi, Shinsuke Uchikawa, Yuji Teraoka, Takuro Uchida, and et al. 2023. "Association of Hepatobiliary Phase of Gadoxetic-Acid-Enhanced MRI Imaging with Immune Microenvironment and Response to Atezolizumab Plus Bevacizumab Treatment" Cancers 15, no. 17: 4234. https://doi.org/10.3390/cancers15174234

Tamura, Y., Ono, A., Nakahara, H., Hayes, C. N., Fujii, Y., Zhang, P., Yamauchi, M., Uchikawa, S., Teraoka, Y., Uchida, T., Fujino, H., Nakahara, T., Murakami, E., Tsuge, M., Serikawa, M., Miki, D., Kawaoka, T., Okamoto, W., Imamura, M., ... Oka, S. (2023). Association of Hepatobiliary Phase of Gadoxetic-Acid-Enhanced MRI Imaging with Immune Microenvironment and Response to Atezolizumab Plus Bevacizumab Treatment. Cancers, 15(17), 4234. https://doi.org/10.3390/cancers15174234